| 标题 |
Abstract RF6-01: Trastuzumab deruxtecan (T-DXd) vs trastuzumab emtansine (T-DM1) in patients with high-risk human epidermal growth factor receptor 2-positive (HER2+) primary breast cancer (BC) with residual invasive disease after neoadjuvant therapy: Interim analysis of DESTINY-Breast05 |
| 网址 | |
| DOI |
10.1158/1557-3265.sabcs25-rf6-01
doi
|
| 其它 |
期刊:Clinical Cancer Research 作者:S. Loibl; Y. Park; Z. Shao; C. Huang; C. H. Barrios; et al 出版日期:2026-02-17 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)